Navigation Links
THORACOPORT™ (Single Use Trocars With Non-conductive Sleeves)

ProductsTHORACOPORT™ (Single Use Trocars With Non-conductive Sleeves)
Company Autosuture
Item THORACOPORT™ (Single Use Trocars With Non-conductive Sleeves)
Features 
  • Single use
  • Non-conductive sleeves
  • Blunt-tipped obturator
  • Threaded sleeve with a shroud at its proximal end
  • Threaded sleeve will grip tissue to reduce slippage during instrument manipulation
  • Disposable
  • 5.5 mm, 10.5 mm, 11.5 mm and 15 mm
  • 12 units per box
    • Description Single use trocar with non-conductive sleeves for gaining and maintaining thoracic access.

    THORACOPORT™ devices are trocars used to gain access to the thoracic cavity for use in video assisted thoracic surgery cases.
    Info Autosuture
    Customer Service: (800) 722-8772
    Web site: http://www.autosuture.com

    Related medicine products :

    1. THORACOPORT™ Soft (Single Use Trocars With Conductive Sleeves)
    2. Uric Acid (Uricase) (Single Reagent)
    3. Cholesterol (Single reagent)
    4. Dual Lock™ (Single And Double) Pivot Under-Table Shield
    5. SPRING-GRIP™ (Single Use Non-conductive Anchoring Devices)
    6. SURGINEEDLE™ (Single Use Pneumoperitoneum Needles)
    7. VERSAPORT™ Plus V2 (Single Use Converterless Trocar System)
    8. VERSAPORT™ Plus RPF (Single Use Converterless Trocar System)
    9. VERSAPORT™ Plus V2 RT (Single Use Obturators)
    10. VISIPORT™ Plus RPF (Single Use Optical Trocar With VERSAPORT™ Plus RPF Converterless Trocar Sleeve)
    11. BLUNTPORT Plus (Single Use Converterless 5 mm-12 mm Trocar System for Open Laparoscopy)
    ...r. This high output compressor can shorten the tre...e patient's lungs. When combined with the PARI LC ... the particle size of medications are optimized fo...ss medication wasted, the patients with asthma, cy...
    ...ealthcares Timeter® PCS 414 portable air compr...s that you may wonder if its running. Youll like i...-resistant steel case thats easy to clean and main...CS 414 has been engineered for maximum efficiency ...
    The most compact, portable DC powered compressor nebulizer system available. The CompAir Elite provides the freedom to take nebulizer treatments away from home. The system is powered by the included
    The 45 PSI SuperSportNeb provides superior performance that translates to shorter treatment times. Like the SportNeb, it is constructed with die-cast aluminum compressor components for consistent rel
    Medicine Products:
    (Date:12/3/2008)...008 Forest Laboratories,...een notified of an unsolicited mini-tender offer b..., a private investment company. Forest Laboratori...hase up to 3.0 million outstanding shares of the c...1 per cent of its outstanding shares. The offer p...
    (Date:12/3/2008)...if., Dec. 3 ThermoGenesi...innovative products and services,that process and...old a,conference call on Thursday, December 4, to...transition at the Company. , The conference...me,(8:30 a.m., Eastern Standard Time). The call c...
    (Date:12/3/2008)... to change therapeutic guidelines, , ,...t contains two blood pressure drugs was more effec...e risk of serious cardiovascular problems and deat... a study that included more than 11,000 patients i...inland. , The patients took either a tablet con...
    (Date:12/3/2008)...al 2% Growth in the Baccalaureate Student Populati... Capacity , , WASHINGTON, Dec. 3 /PRNewsw...leges of Nursing (AACN) today released preliminary...l baccalaureate nursing programs increased by only... the eighth consecutive year of enrollment growth,...
    Breaking Medicine News(10 mins):Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 3Health News:ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition 2Health News:Blood Pressure Pill Combo More Effective Than Diuretics 2Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 2Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 3Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 4Health News:Enrollment Growth in U.S. Nursing Colleges and Universities Hits an 8-Year Low According to New Data Released by AACN 5
    ...tion sumatriptan, known by the brand names Imitrex...trigeminal neuralgia up to eight hours. Now resea... provide relief for people who suffer from, trigem...ed the drug and found it produced rapid and signif...
    ... women with hypertension compared to those with no...tion of hypertension appear to be significant pred...in sexual desire, arousal, inability to achieve an...rse, a study presented at the 21st Annual Meeting ...
    ...ern Ireland, expressing his apology over the cance...center//, has stated that women who had suffered d...arming report had pointed out the delay in the can...tandard care of a consultant radiologist. ‘The est...
    ...tility procedures such as in-vitro fertilization a...ractice. // But a study published in the May issue...er thorough screenings of sperm donors, genetic di...eived children. Laurence Boxer, MD, and colleague...
    Other Medicine News:Health News:Study Finds That Migraine Drug Can Ease The Severest Of Facial Pain 2Health News:Minster Apologizes To Women Involved In Breast Cancer Screening Scandal 2
    (Date:12/3/2008).... 3 Isogen, a contract development...ng, announced it has retained a,strategic financi...e global,biopharma demand for Isogen,s services. ...ful first round series of capital,investment and ...Q1 2009 to,deliver on the previously unmet proces...
    (Date:12/2/2008)...PRNewswire-USNewswire/ -- Breast-specific gamma im...cers not found on mammograms or by,clinical exam,...l meeting of,the Radiological Society of North Am... difficult to detect breast cancer-invasive,lobul...D., professor of,radiology and director of the Br...
    (Date:12/2/2008)...c. 2 Micromet, Inc. (Nas...ing novel, proprietary antibodies for the treatmen... today announced that it has entered into an agree...lity (CEFF) with Kingsbridge Capital Limited, a pr...reement, Kingsbridge has committed to provide up t...
    (Date:12/1/2008)... S*BIO Pte Ltd today announced the...8, a potent and orally-active JAK2 inhibitor, in l...ith chronic idiopathic myelofibrosis (CIMF). , ...y and tolerability of SB1518 in patients with CIMF...Phase 1 part of the study will assess the safety p...
    Breaking Medicine Technology:Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Consumers Union Supports Proposed Expansion of Medicare Policy to Withhold Payments to Hospitals That Harm Patients 22322 1Consumers Union Supports Proposed Expansion of Medicare Policy to Withhold Payments to Hospitals That Harm Patients 22322 2Consumers Union Supports Proposed Expansion of Medicare Policy to Withhold Payments to Hospitals That Harm Patients 22322 3Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions 22320 1Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions 22320 2Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions 22320 3Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions 22320 4Data Published in Plastic and Reconstructive Surgery Show Cohera Medicals Surgical Adhesive TissuGlu 28R 29 Prevents Seroma Formation in Animal Abdo 22318 1Data Published in Plastic and Reconstructive Surgery Show Cohera Medicals Surgical Adhesive TissuGlu 28R 29 Prevents Seroma Formation in Animal Abdo 22318 2Data Published in Plastic and Reconstructive Surgery Show Cohera Medicals Surgical Adhesive TissuGlu 28R 29 Prevents Seroma Formation in Animal Abdo 22318 3Integrated Behavioral Health Optimizes Claims Processing With BlueThreads SmartDesk K2 Workflow and Microsoft Office SharePoint Server 22316 1Integrated Behavioral Health Optimizes Claims Processing With BlueThreads SmartDesk K2 Workflow and Microsoft Office SharePoint Server 22316 2Integrated Behavioral Health Optimizes Claims Processing With BlueThreads SmartDesk K2 Workflow and Microsoft Office SharePoint Server 22316 3
    ...emy of Neurology Annual Meeting, BOSTON and SOUTH ... Therapeutics, Inc. (PTC), a biopharmaceutical com...mall-molecule drugs targeting,post-transcriptional...im data from a Phase 2 clinical trial of PTC124 in...ue to a nonsense mutation.,The results from the fi...
    ...sh; Isotechnika Inc.,(TSX:ISA) announced today tha...to as LX211 by our partner Lux Biosciences, has,be... the,Association for Research in Vision and Ophtha... in Fort Lauderdale, Florida. , , The first, an ...tellite session of the American Uveitis Society by...
    Other Medicine Technology:PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 5Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting 2Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting 3Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting 4